NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring...
Zacks.com